Syndicated Report

Awareness of Nucleic Acid-Based Therapies

October 24, 2019

In this Syndicated Report we had two goals:

  • Provide a baseline understanding of current knowledge among physicians regarding the types of nucleic acid-based therapies, their mechanisms of action, and their current and future promise.
  • Serve as a vehicle for future surveys to assess how knowledge and perceptions change over time.

Methodology: 12-Minute MicroSurvey
Crowds: PCPs, Oncologists, & Pediatricians
Sample Size: n=250
Fielding Period:
September 8-10, 2019

This report explores physician awareness of the following RNA- or DNA-based therapeutic methods:

  • RNAi (RNA interference)
  • siRNA (short interfering RNAs)
  • ASO (antisense oligonucleotides)
  • mRNA (messenger ribonucleic acid)
  • AAV (adeno-associated virus)
  • CRISPR (clustered regularly interspaced short palindromic repeats)
  • TALENs (transcription activator-like effector nuclease)

Download the report now!

    InCrowd uses the information you provide to us to contact you about our relevant insights, products, and services. You may opt out of communications at any time via the unsubscribe link at the bottom of any email or by sending an email withdrawing your consent to Send Email. For more information, please review our Privacy Policy.
  • This field is for validation purposes and should be left unchanged.